Yusen Logistics Benelux Belgium Pharmaceutical Import Profile — Belgium (DGFT 2022–2026)

Name: Yusen Logistics Benelux Belgium Pharmaceutical Import Records from India — 42 Products, $279.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Yusen Logistics Benelux Belgium — Pharmaceutical Importer Profile (2026) | 42 Products, $279.0M Trade | TransData Nexus

Yusen Logistics Benelux Belgium

Pharmaceutical Importer · Belgium · Gastrointestinal Focus · $279.0M Total Trade · DGFT Verified

Yusen Logistics Benelux Belgium is a pharmaceutical importer based in Belgium with a total trade value of $279.0M across 42 products in 12 therapeutic categories. Based on 7,629 verified import shipments from Indian Customs (DGFT) records, Yusen Logistics Benelux Belgium is the #1 buyer in 9 products including Esomeprazole, Magnesium, Omeprazole. Yusen Logistics Benelux Belgium sources from 2 verified Indian suppliers, with Sun Pharmaceutical Industries Limited accounting for 96.6% of imports.

Yusen Logistics Benelux Belgium — Import Portfolio & Supplier Network

Yusen Logistics Benelux Belgium import network — 42 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Yusen Logistics Benelux Belgium?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Sun Pharmaceutical Industries Limited	$238.7M	9,651	96.6%
Sun Pharmaceutical Industries Ltd	$8.4M	349	3.4%

Yusen Logistics Benelux Belgium sources from across .

What Formulations Does Yusen Logistics Benelux Belgium Import?

Formulation	Value	Ships
Esomeprazole magnesium gastro	$4.7M	140
Pantoprazol Gastro-Resistant tablets 40MG ( pantoprazol basics TAB 40MG ) Each tablet contains: pantoprazole sodium	$1.7M	77
Pantoprazol Gastro-Resistant tablets	$1.7M	42
Levetiracetam tablets 1000MG	$1.4M	41
Pantoprazole Gastro-Resistant tablets	$1.3M	44
Contiflo xl capsules 0.4MG Pack	$1.1M	23
Gabapentin capsules 300MG ( gabaran CAPS	$1.0M	23
Ramoclav tablets 875/125MG (amoxiclav	$1.0M	22
Atorvastatin calcium tablets 20MG	$1.0M	48
Simvastatin tablets 20MG ( simva	$978.5K	32
Atorvastatin calcium tablets 20MG ( atorvastatin sun fc TAB 20MG ) Each Film-Coated tablet contains: atorvastatin calciu	$949.0K	77
Atorvastatin calcium tablets 40MG	$878.7K	35
Levetiracetam tablets 500MG	$812.0K	29
Memantine hydrochloride tablets 10MG	$776.7K	20
Valsartan tablets 160MG ( valsartan	$775.5K	20

Yusen Logistics Benelux Belgium imports 5,230 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 30 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Esomeprazole	Gastrointestinal	$31.6M	632	6.9%	1
2	Magnesium	Vitamins & Supplements	$29.6M	591	8.2%	1
3	Calcium	Vitamins & Supplements	$23.5M	939	2.6%	7
4	Omeprazole	Gastrointestinal	$20.4M	407	3.2%	1
5	Strip	Medical Devices & Diagnostics	$16.4M	328	8.3%	3
6	Pantoprazole	Gastrointestinal	$15.9M	523	1.2%	5
7	Atorvastatin	Cardiovascular	$14.7M	663	1.4%	10
8	Sertraline	CNS & Psychiatric	$14.1M	281	2.5%	2
9	Rosuvastatin	Cardiovascular	$12.3M	341	2.7%	8
10	Clarithromycin	Antibiotics	$9.2M	186	9.3%	2
11	Citalopram	CNS & Psychiatric	$8.9M	179	3.5%	4
12	Simvastatin	Cardiovascular	$8.9M	368	7.1%	2
13	Meropenem	Advanced Antibiotics	$7.2M	143	3.2%	1
14	Gabapentin	CNS & Psychiatric	$6.2M	123	0.7%	14
15	Fluconazole	Antifungals	$5.1M	123	5.5%	2
16	Gemcitabine	Oncology	$5.1M	116	10.9%	1
17	Syringe	Medical Devices & Diagnostics	$4.8M	95	2.6%	2
18	Temozolomide	Advanced Oncology	$4.7M	184	19.9%	1
19	Valsartan	Cardiovascular	$4.5M	187	2.3%	8
20	Fenofibrate	Lipid & Metabolism	$3.7M	74	5.0%	1
21	Ezetimibe	Lipid & Metabolism	$3.4M	99	0.7%	7
22	Cefuroxime	Advanced Antibiotics	$3.1M	93	2.4%	4
23	Irinotecan	Oncology	$2.8M	78	6.7%	2
24	Irbesartan	Cardiovascular	$2.6M	144	2.4%	8
25	Lenalidomide	Advanced Oncology	$2.5M	79	0.3%	9
26	Tobramycin	Antibiotics	$2.4M	47	6.0%	4
27	Oxaliplatin	Advanced Oncology	$2.2M	94	4.8%	4
28	Escitalopram	CNS & Psychiatric	$2.1M	93	1.1%	11
29	Ramipril	Cardiovascular	$1.8M	143	2.0%	11
30	Imipenem	Advanced Antibiotics	$1.6M	31	4.6%	2

Yusen Logistics Benelux Belgium imports 42 pharmaceutical products across 12 categories into Belgium totaling $279.0M. The company is the #1 buyer for 9 products: Esomeprazole, Magnesium, Omeprazole, Meropenem, Gemcitabine.

Yusen Logistics Benelux Belgium — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Yusen Logistics Benelux Belgium is a subsidiary of Yusen Logistics (Benelux) B.V., a logistics and supply chain management company headquartered in Moerdijk, Netherlands. (craft.co) The company specializes in providing comprehensive logistics services, including air and ocean freight forwarding, warehousing, distribution, and supply chain management. In Belgium, Yusen Logistics operates as a third-party logistics (3PL) provider, focusing on the pharmaceutical and healthcare sectors. The Belgian branch is located at Keetberglaan 2, 9120 Melsele, Belgium. (trendstop.knack.be)

Yusen Logistics Benelux is part of the global Yusen Logistics network, which is a subsidiary of Nippon Yusen Kabushiki Kaisha (NYK Line), one of the world's largest shipping companies. (craft.co) The company plays a significant role in Belgium's pharmaceutical supply chain by offering specialized logistics services tailored to the needs of pharmaceutical companies. This includes the importation and distribution of finished pharmaceutical formulations, as evidenced by TransData Nexus proprietary trade data indicating that Yusen Logistics Benelux Belgium imported $279.0 million USD worth of finished pharmaceutical products from India between 2022 and 2026.

2Distribution Network

Yusen Logistics Benelux operates multiple warehouse facilities in Belgium to support its logistics operations. Notably, the company has a facility in Melsele, near Antwerp, which was expanded in July 2020 to include a new warehouse offering space for up to 15,000 pallets over nearly 5,000 square meters at a height of 17 meters. Additionally, in June 2024, Yusen Logistics, in collaboration with MG Real Estate and GSK, inaugurated a new 40,000 square meter pharmaceutical warehouse in Gembloux, Wallonia. This facility is the largest biopharmaceutical logistics center in Wallonia and features advanced technologies such as automated mobile robots and automated packaging systems. (mgrealestate.eu)

Yusen Logistics Benelux Belgium serves as a critical logistics intermediary within Belgium's pharmaceutical supply chain. The company's role encompasses the importation, storage, and distribution of finished pharmaceutical products, ensuring that these products are efficiently and safely delivered to various stakeholders, including wholesalers, hospitals, and pharmacies. The company's significant import activities, particularly from Indian pharmaceutical manufacturers, highlight its pivotal position in facilitating the availability of a diverse range of pharmaceutical products in the Belgian market.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Yusen Logistics Benelux Belgium

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Yusen Logistics Benelux Belgium's import data from India between 2022 and 2026 indicates a significant reliance on a single supplier. Out of a total import value of $279.0 million USD across 7,629 shipments, a substantial $238.7 million (approximately 85.6%) was sourced from SUN PHARMACEUTICAL INDUSTRIES LIMITED, accounting for 9,651 shipments. An additional $8.4 million (3.0%) came from SUN PHARMACEUTICAL INDUSTRIES LTD, with 349 shipments. This results in a combined supplier concentration of 88.6% from these two entities, leaving only 11.4% of imports diversified among other suppliers.

Such a high level of supplier concentration poses potential risks. While a strong relationship with a primary supplier can ensure consistent quality and streamlined operations, over-reliance on a single source may expose the company to supply disruptions due to unforeseen events affecting the supplier. Additionally, this dependency can diminish Yusen Logistics' negotiating leverage, potentially leading to less favorable pricing and terms. Industry benchmarks suggest that for non-specialized categories, a Herfindahl-Hirschman Index (HHI) below 1,500 indicates low concentration, while above 2,500 signifies high concentration. In this context, Yusen's supplier concentration would likely fall into the high category, indicating a need for diversification to mitigate associated risks.

2Supply Chain Resilience

Importing Pharmaceuticals into Belgium — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Belgium

1Regulatory Authority & Framework

In Belgium, the Federal Agency for Medicines and Health Products (FAMHP) serves as the national regulatory authority overseeing the importation and distribution of pharmaceutical products. The primary legislation governing these activities includes the Royal Decree of 14 December 2006, which regulates medicinal products for human use.

For Indian generic pharmaceuticals to be marketed in Belgium, they must obtain a marketing authorization. This process involves submitting a comprehensive dossier to the FAMHP, detailing the product's quality, safety, and efficacy. The authorization can be pursued through national procedures or via the European Medicines Agency (EMA) for centralized approval, depending on the product's classification and intended market reach.

2Import Licensing & GMP

Importing pharmaceutical products into Belgium requires a Manufacturing and Import Authorization (MIA), which mandates compliance with Good Manufacturing Practice (GMP) standards. The EU recognizes GMP certificates from countries with Mutual Recognition Agreements (MRAs); however, India is not currently among these countries. Consequently, Indian manufacturing sites must undergo inspections by EU authorities to ensure GMP compliance. Additionally, entities involved in the wholesale distribution of pharmaceuticals must obtain a Wholesale Distribution Authorization (WDA) from the FAMHP, ensuring adherence to Good Distribution Practice (GDP) guidelines.

Yusen Logistics Benelux Belgium — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Yusen Logistics Benelux Belgium's import data from India between 2022 and 2026 reveals a strategic focus on specific therapeutic areas. The top three categories—Gastrointestinal (24.3%), Vitamins & Supplements (19.0%), and Cardiovascular (16.2%)—account for nearly 60% of their imports. This concentration suggests a deliberate alignment with prevalent health concerns in Belgium, such as digestive disorders, nutritional deficiencies, and heart-related conditions. The emphasis on these categories indicates a response to substantial market demand, aiming to address common health issues within the population.

The prominence of products like Esomeprazole ($31.6M), Magnesium ($29.6M), and Omeprazole ($20.4M) further underscores this strategy. Esomeprazole and Omeprazole are widely used for treating acid reflux and related gastrointestinal conditions, while Magnesium supplements cater to nutritional needs. By prioritizing these products, Yusen Logistics demonstrates a commitment to supplying medications that are essential for managing prevalent health concerns in Belgium.

2Sourcing Profile

Yusen Logistics Benelux Belgium's procurement strategy heavily favors generic pharmaceuticals, as evidenced by their substantial imports from Indian suppliers. Notably, 96.6% of their imports, amounting to $238.7M, were sourced from SUN PHARMACEUTICAL INDUSTRIES LIMITED, with an additional $8.4M (3.4%) from SUN PHARMACEUTICAL INDUSTRIES LTD. This reliance on a single supplier for the majority of their imports indicates a preference for cost-effective generic medications, which are integral to their supply chain.

Seller's Guide — How to Become a Supplier to Yusen Logistics Benelux Belgium

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

Given the current supplier concentration, opportunities for new Indian pharmaceutical exporters to collaborate with Yusen Logistics Benelux Belgium appear limited. Sun Pharmaceutical Industries Limited's substantial market share indicates a strong, established relationship, potentially leaving minimal room for additional suppliers. However, potential gaps may exist in therapeutic categories beyond the top three, or in niche products not currently supplied by existing partners. Identifying these specific areas could present entry points for new suppliers.

2Requirements & Qualifications

To engage with Yusen Logistics Benelux Belgium and the broader Belgian market, Indian pharmaceutical exporters must adhere to stringent quality and regulatory standards. Essential certifications include:

Good Manufacturing Practice (GMP): Compliance with GMP standards, as recognized by the European Medicines Agency (EMA), is mandatory to ensure product quality and safety.

Frequently Asked Questions — Yusen Logistics Benelux Belgium

Who supplies pharmaceutical formulations to Yusen Logistics Benelux Belgium from India?

Who supplies pharmaceutical formulations to Yusen Logistics Benelux Belgium from India? Yusen Logistics Benelux Belgium primarily sources its pharmaceutical formulations from two verified Indian suppliers: SUN PHARMACEUTICAL INDUSTRIES LIMITED, accounting for $238.7 million USD (96.6% of total imports), and SUN PHARMACEUTICAL INDUSTRIES LTD, contributing $8.4 million USD (3.4%). These two suppliers collectively fulfill the company's import requirements from India.

How much does Yusen Logistics Benelux Belgium import in pharmaceutical formulations from India?

How much does Yusen Logistics Benelux Belgium import in pharmaceutical formulations from India? Between 2022 and 2026, Yusen Logistics Benelux Belgium imported pharmaceutical formulations from India totaling $279.0 million USD, distributed over 7,629 shipments. This substantial import activity underscores the company's significant role in the pharmaceutical supply chain between India and Belgium.

What pharmaceutical products does Yusen Logistics Benelux Belgium import?

What pharmaceutical products does Yusen Logistics Benelux Belgium import? The company imports 42 distinct pharmaceutical products across 12 therapeutic categories. The top five products by import value are Esomeprazole ($31.6 million USD), Magnesium ($29.6 million USD), Calcium ($23.5 million USD), Omeprazole ($20.4 million USD), and Strip ($16.4 million USD). These products collectively represent 43.5% of the company's total import portfolio.

Which Indian pharmaceutical companies are verified suppliers to Yusen Logistics Benelux Belgium?

Which Indian pharmaceutical companies are verified suppliers to Yusen Logistics Benelux Belgium? Yusen Logistics Benelux Belgium's verified Indian suppliers are SUN PHARMACEUTICAL INDUSTRIES LIMITED and SUN PHARMACEUTICAL INDUSTRIES LTD. SUN PHARMACEUTICAL INDUSTRIES LIMITED is the predominant supplier, accounting for 96.6% of the total import value, while SUN PHARMACEUTICAL INDUSTRIES LTD contributes 3.4%.

Get Full Yusen Logistics Benelux Belgium Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

Yusen Logistics Benelux Belgium

Yusen Logistics Benelux Belgium — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Yusen Logistics Benelux Belgium?

What Formulations Does Yusen Logistics Benelux Belgium Import?

What Products Does Yusen Logistics Benelux Belgium Import?

Top Products by Import Value

Yusen Logistics Benelux Belgium Therapeutic Categories — 12 Specializations

Import Portfolio — Top 30 by Import Value

All 42 Products

Key Metrics

Top Categories

Indian Suppliers

Related Trade Data

Need Detailed Data?

Yusen Logistics Benelux Belgium — Corporate Profile & Information

1Company Overview

2Distribution Network

Supplier Relationship Intelligence — Yusen Logistics Benelux Belgium

1Sourcing Concentration Analysis

2Supply Chain Resilience

Importing Pharmaceuticals into Belgium — Regulatory Framework

1Regulatory Authority & Framework

2Import Licensing & GMP

Yusen Logistics Benelux Belgium — Procurement Pattern Analysis

1Product Strategy

2Sourcing Profile

Seller's Guide — How to Become a Supplier to Yusen Logistics Benelux Belgium

1Opportunity Assessment

2Requirements & Qualifications

Frequently Asked Questions — Yusen Logistics Benelux Belgium

Who supplies pharmaceutical formulations to Yusen Logistics Benelux Belgium from India?

How much does Yusen Logistics Benelux Belgium import in pharmaceutical formulations from India?

What pharmaceutical products does Yusen Logistics Benelux Belgium import?

Which Indian pharmaceutical companies are verified suppliers to Yusen Logistics Benelux Belgium?

Get Full Yusen Logistics Benelux Belgium Import Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Data Source & Methodology

3Strategic Implications

3Quality & Labeling

4Recent Regulatory Changes

3Market Positioning

3How to Approach

What therapeutic categories does Yusen Logistics Benelux Belgium focus on?

How concentrated is Yusen Logistics Benelux Belgium's supplier base?

What formulation types does Yusen Logistics Benelux Belgium import from India?

How can an Indian pharmaceutical company become a supplier to Yusen Logistics Benelux Belgium?

What quality certifications does Yusen Logistics Benelux Belgium require from Indian suppliers?

What is Yusen Logistics Benelux Belgium's importing pattern and order frequency?

Analysis Methodology